Guillermo Juarez-Vega (Guillermo Juárez-Vega)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Prognostic Factors

Ejection Fraction

Coronavirus Disease

Top Venues

International journal of molecular sciences

Clinical and translational medicine

Journal of leukocyte biology

This page only lists publications with an associated author ORCID identifier.

Publications

Karina Santana-de Anda, Jiram Torres-Ruiz, Nancy Raquel Mejía-Domínguez, Beatriz Alcalá-Carmona, José Luis Maravillas-Montero, José Carlos Páez-Franco, Ana Sofía Vargas-Castro, Jaquelin Lira-Luna, Emmanuel A Camacho-Morán, Guillermo Juarez-Vega, David Meza-Sánchez, Carlos Núñez-Álvarez, Marina Rull-Gabayet, Diana Gómez-Martín
Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome. International journal of molecular sciences 25 (17) (2024)
Fatima Lopez-Leal, Tecilli Cabellos-Avelar, Diego A Correa-Becerril, Brenda Juarez-Macias, Rodrigo Cervantes-Diaz, Raul F Reyes-Huerta, Guillermo Juarez-Vega, Daniel Gutierrez-Castaneda, Tannya Karen Castro-Jimenez, Bustos-Arriaga José, José Luis Maravillas-Montero, Araceli Perez-Lopez
Blockade of the CCR3 receptor reduces neutrophil recruitment to the lung during acute inflammation. Journal of leukocyte biology (2024)
Jiram Torres-Ruiz, Julieta Lomelín-Gascón, Jaquelin Lira-Luna, Alfredo Pérez-Fragoso, Roberto Tapia-Conyer, Miroslava Nuñez-Aguirre, Beatriz Alcalá-Carmona, Abdiel Absalón-Aguilar, José Luis Maravillas-Montero, Nancy Raquel Mejía-Domínguez, Carlos Alberto Núñez-Álvarez, Luis Llorente, Sandra Romero-Ramírez, Victor Andrés Sosa-Hernández, Rodrigo Cervantes-Diaz, Guillermo Juarez-Vega, David E Meza-Sánchez, Marina Rull-Gabayet, Luis-Alberto Martínez-Juárez, Linda Morales-Juárez, Lizeth Naomi López-López, José Adrián Negrete-Trujillo, Jorge Abelardo Falcón-Lezama, Rafael Ricardo Valdez-Vázquez, Héctor Gallardo-Rincón, Diana Gómez-Martín
FANSY POSTCOV: A composite clinical immunological predictive index for post-COVID-19 syndrome unveils distinctive features in a cohort study of mild to critical patients. Clinical and translational medicine 11 (11) (2021)